🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Impressive work in Nature Medicine using functional precision medicine to find new therapy approaches in #gbm patients. Congrats to friends in Weller and Snijder labs! #fpm rdcu.be/dU95p

PCV benefit vs TMZ in #oligodendroglioma from POLA Network and Mehdi Touat lab on Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma | Journal of

Team Pathology is walking Now in the The Jimmy Fund Walk!! Donate now to help fund cancer research!

Spatial and functional visualization of tau from the Hyman lab! In situ seeding assay: A novel technique for direct tissue localization of bioactive tau academic.oup.com/jnen/article-a…

Congrats Azra!

Congrats David! Wonderful to see your groundbreaking work Mass General Brigham Pathology Brigham and Women's Pathology Dana-Farber receiving accolades and having you as a colleague. #PrecisionMedicine

CAR T cells, CAR NK cells, and CAR macrophages exhibit distinct traits in glioma models but are similarly enhanced when combined with cytokines: Cell Reports Medicine cell.com/cell-reports-m…

Check out our latest work on MDM2 as a validated target in #gbm. Super collaboration with Veronica Rendo Kalem Lee Sandro Santagata Rameen Beroukhim Patrick Wen and team Kartos Therapeutics and the patients who contributed science.org/doi/10.1126/sc…

CAP urges HHS to revoke lab developed test rule, citing Trump order medtechdive.com/news/cap-hhs-l… via MedTech Dive

Explainable artificial intelligence of DNA methylation-based brain tumor diagnostics - Nice work from friends in the volker hovestadt lab and in Heidelberg on deeper understanding of drivers of classification nature.com/articles/s4146…

Great opportunity to help develop and translate Dana-Farber diagnostics for patients. careers.dana-farber.org/job/11134/busi…

Breaking News: Court Throws Out LDT Rule. “The FDA’s LDT rulemaking was burdensome, and the court rightly struck it down,” said CAP President Donald Karcher, MD, FCAP. “The CAP and its members are relieved that the court agreed with our arguments.” brnw.ch/21wRHqD

We’re on our way to #AACR25! Whether you'll be in Chicago April 25-30 or attending virtually, follow Dana-Farber News for important research findings by Dana-Farber faculty across a spectrum of cancers. Complete list of DFCI oral abstracts: bit.ly/42Q5F1a

Great story from Burns lab highlighting some of the exciting things happening in Dana-Farber Pathology

Check out #AACR25 presentation of the National Cancer Institute Human Cancer Models Initiative update by postdoc Dina ElHarouni at 3pm today! 600+ organoid and NextGen patient models of cancer. Great collaboration with whole HCMI team ADuong Broad Institute LigonLab and Cancer Cell Line Factory

Check out poster Today 9am at #AACR25 by amazing postdoc and future pathologist Georges Ayoub and friends on pathologist-oriented AI automated and quantitative digital pathology approaches defining pathological response in #gbm Dana-Farber News Break Through Cancer Mass General Brigham Pathology

Heterogeneity only now coming in view through large scale efforts - this clearly demonstrates how in #gbm and other heterogeneous cancers if we don’t study 100+ patients then we are not going to solve the problem. Thx to all for opp to contribute to this effort.

Great review from friends and former BWH Neuropathology Brigham and Women's Pathology colleagues Rebecca Folkerth and Barbara Sampson on Forensic Pathology | New England Journal of Medicine nejm.org/doi/full/10.10…